Molecular Biology Reports

, Volume 39, Issue 3, pp 3245–3249 | Cite as

The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population

  • Soykan Arıkan
  • Canan Cacina
  • Erkan Guler
  • Serdar Çulcu
  • Gulay Tuna
  • İlhan Yaylım-Eraltan


Endothelial nitric oxide synthase (eNOS), coded by the gene NOS3, may play an important role in uncontrollable cellular growth in several cancer types. Our study was performed to test the association between Glu298Asp polymorphisms in the NOS3 gene and colorectal cancer risk and progression. In this study, NOS3 Glu298Asp polymorphism was genotyped in 84 patients with colorectal cancer and 99 healthy subjects using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis. There were significant differences in the distribution of NOS3 genotypes and frequencies of the alleles between colorectal cancer patients and controls (P = 0.016, P = 0.006, respectively). The increased frequency of NOS3 Glu298Asp homozygotes genotypes in patients who had advanced tumour stage was statistically significant (P = 0.042). Our findings have suggested that NOS3 Glu298Asp polymorphism might be associated with the risk and progression of colorectal cancer in Turkish population.


NOS3 Colorectal cancer Risk Progression Polymorphism 



This study was supported by a grant from Istanbul University, Research Foundation (Project 488/05052006), Turkey. We are also grateful to the cancer epidemiologist Dr. Hakan Camlica for support and correction of statistical analysis.


  1. 1.
    Potter JD (1999) Related colorectal cancer: molecules and populations. J Natl Cancer Inst 91:916–932PubMedCrossRefGoogle Scholar
  2. 2.
    Ames BN (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221:1256–1264PubMedCrossRefGoogle Scholar
  3. 3.
    Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435–7451PubMedCrossRefGoogle Scholar
  4. 4.
    Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19:711–721PubMedCrossRefGoogle Scholar
  5. 5.
    Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54:52–413Google Scholar
  6. 6.
    Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S (1995) Nitric oxide synthase activity in human breast cancer. Br J Cancer 72:41–44PubMedCrossRefGoogle Scholar
  7. 7.
    Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA (1995) Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55:727–730PubMedGoogle Scholar
  8. 8.
    Kimura H, Esumi H (2003) Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 50:49–59PubMedGoogle Scholar
  9. 9.
    Xu W, Charles IG, Moncada S, Gorman P, Sheer D, Liu L, Emson P (1994) Mapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectively. Genomics 21:419–422PubMedCrossRefGoogle Scholar
  10. 10.
    Rossi GP, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina AC (2003) The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41:930–937PubMedCrossRefGoogle Scholar
  11. 11.
    Awata T, Neda T, Iizuka H, Kurihara S, Ohkubo T, Takata N, Osaki M, Watanabe M, Nakashima Y, Sawa T, Inukai K, Inoue I, Shibuya M, Mori K, Yoneya S, Katayama S (2004) Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care 27:2184–2190PubMedCrossRefGoogle Scholar
  12. 12.
    Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Lopes C (2002) Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev 11:343–350PubMedCrossRefGoogle Scholar
  13. 13.
    Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, Gitsch G, Leodolter S, Tempfer CB (2004) Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol Oncol 93:686–690PubMedCrossRefGoogle Scholar
  14. 14.
    Hefler LA, Ludwig E, Lampe D, Zeillinger R, Leodolter S, Gitsch G, Koelbl H, Tempfer CB (2002) Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol Oncol 86:134–137PubMedCrossRefGoogle Scholar
  15. 15.
    Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, Nakao K (1998) A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103:65–69PubMedCrossRefGoogle Scholar
  16. 16.
    Rao CV (2004) Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 555:107–119PubMedCrossRefGoogle Scholar
  17. 17.
    Metzger IF, Serto′rio JT, Tanus-Santos JE (2007) Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 43:987–992PubMedCrossRefGoogle Scholar
  18. 18.
    Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate versus glutamate at position 298. Proc Natl Acad Sci USA 97:2832–2835PubMedCrossRefGoogle Scholar
  19. 19.
    Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, Mourad M, Horie S, Feron O, Balligand JL, Wattiez R, Pirson Y, Chauveau D, Lens XM, Devuyst O (2002) Modifier effect of NOS3 in autosomal dominant polycystic kidney disease. Hum Mol Genet 11:229–241PubMedCrossRefGoogle Scholar
  20. 20.
    Miller SA, Dykes DD, Polesky HF (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215CrossRefGoogle Scholar
  21. 21.
    Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K (1998) Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32:3–8PubMedGoogle Scholar
  22. 22.
    Ying L, Hofseth LJ (2007) Emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 67:1407–1410PubMedCrossRefGoogle Scholar
  23. 23.
    Lu J, Wei Q, Bondy ML, Yu TK, Li D, Brewster A, Shete S, Sahin A, Meric-Bernstam F, Wang LE (2006) Promoter polymorphism (786t > C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer 107:2245–2253PubMedCrossRefGoogle Scholar
  24. 24.
    Choi JY, Lee KM, Noh DY, Ahn SH, Lee JE, Han W, Jang IJ, Shin SG, Yoo KY, Hayes RB, Kang D (2006) Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer. Breast Cancer Res Treat 100:213–218PubMedCrossRefGoogle Scholar
  25. 25.
    Medeiros RM, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Ferreira P, Lopes C (2002) Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clin Cancer Res 8:3433–3437PubMedGoogle Scholar
  26. 26.
    Yang J, Ambrosone CB, Hong C-C, Ahn J, Rodriguez C, Thun MJ, Calle EE (2007) Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer. Carcinogenesis 28:1247–1253PubMedCrossRefGoogle Scholar
  27. 27.
    Sonveaux P, Jordan BF, Gallez B, Feron O (2009) Nitric oxide delivery to cancer: why and how? Eur J Cancer 45:1352–1369PubMedCrossRefGoogle Scholar
  28. 28.
    Conde MC, Ramirez-Lorca R, Lopez-Jamar JME, Molero E, Ramirez-Armengol JA, Nogueira JAM, Pascual MH, Ruiz A, Martin-Cordova CG, Real LM, Royo JL (2006) Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol Rep 16:353–359PubMedGoogle Scholar
  29. 29.
    Yeh CC, Santenalla RM, Hsieh LL, Sung FC, Tang R (2009) An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int J Cancer 124:1565–1571PubMedCrossRefGoogle Scholar
  30. 30.
    Mozet C, Marin DG, Bertolini J, Tannapfel A, Wichmann G, Dietz A (2009) Nitric oxide synthase (NOS2/3) expression in head and neck squamous cell carcinomas in correlation with clinical patterns. Onkologie 32:655–660PubMedCrossRefGoogle Scholar
  31. 31.
    Fujita S, Masago K, Hatachi Y, Fukuhara A, Hata A, Kaji R, Kim YH, Mio T, Mishima M, Katakami N (2010) Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small lung cancer patients treated with platinum-based doublet chemotherapy. BMC Med Genet 11:167PubMedCrossRefGoogle Scholar
  32. 32.
    Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kron AA, de Leeuw PW, Smits P (2002) The Glu298Asp polymorphism of the NOS3 gene as a determinant of the baseline production of nitric oxide. J.Hypertens 20:2023–2027PubMedCrossRefGoogle Scholar
  33. 33.
    Moochhala S, Chhatwal VJ, Chan ST, Ngoi SS, Chia YW, Rauff A (1996) Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 17:1171–1174PubMedCrossRefGoogle Scholar
  34. 34.
    Yu JX, Cui L, Zhang QY, Chen H, Ji P, Wei HJ, Ma HY (2006) Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J Gastroenterol 12:4660–4664PubMedGoogle Scholar
  35. 35.
    Mortensen K, Christensen IJ, Nielsen HJ, Hansen U, Larsson LI (2004) High expression of endothelial cell nitric oxide synthase in peritumoral microvessels predicts increased diseasefree survival in colorectal cancer. Cancer Lett 216:109–114PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Soykan Arıkan
    • 1
  • Canan Cacina
    • 2
  • Erkan Guler
    • 1
  • Serdar Çulcu
    • 1
  • Gulay Tuna
    • 2
  • İlhan Yaylım-Eraltan
    • 2
  1. 1.Surgery ClinicIstanbul Education and Research HospitalIstanbulTurkey
  2. 2.Department of Molecular Medicine, Institute of Experimental MedicineIstanbul UniversityIstanbulTurkey

Personalised recommendations